Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Net Issuance of Debt : NT$-39.0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Taiwan Advance Bio-Pharmaceutical Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Taiwan Advance Bio-Pharmaceutical's net issuance of debt for the six months ended in Jun. 2024 was NT$-20.6 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-39.0 Mil.

Taiwan Advance Bio-Pharmaceutical Net Issuance of Debt Historical Data

The historical data trend for Taiwan Advance Bio-Pharmaceutical's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Advance Bio-Pharmaceutical Net Issuance of Debt Chart

Taiwan Advance Bio-Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Debt

Get a 7-Day Free Trial

25.41

-5.88

-9.08

33.06

29.76

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Issuance of Debt	Get a 7-Day Free Trial															1.84	31.23	48.16	-18.39	-20.61

Taiwan Advance Bio-Pharmaceutical Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-39.0 Mil.

Taiwan Advance Bio-Pharmaceutical Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Taiwan Advance Bio-Pharmaceutical's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Advance Bio-Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Advance Bio-Pharmaceutical Inc (ROCO:4186) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F., No.25, Ln. 169, Kangning Street, Xizhi Dist, New Taipei City, TWN, 22180

Website

http://www.abc-residue.com

Taiwan Advance Bio-Pharmaceutical Inc operates in the food safety industry. The company's product includes Food safety test kit, Animal test kit, Pesticide test kit, Mycotoxin test kit, Nuleic acid extraction kit.

Taiwan Advance Bio-Pharmaceutical Headlines

No Headlines